X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/27/2853034/0/en/Coave-Therapeutics-to-Present-at-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2024/02/29/2837821/0/en/Coave-Therapeutics-Receives-Grant-from-the-ALS-Association-to-Advance-its-CTx-TFEB-Program-as-a-Potential-Treatment-for-All-Forms-of-ALS.html
https://www.globenewswire.com//news-release/2023/10/12/2759079/0/en/Coave-Therapeutics-appoints-Leading-World-Experts-to-newly-formed-Scientific-Advisory-Board-dedicated-to-its-Genetic-Medicine-Delivery-Platform.html
https://www.globenewswire.com//news-release/2023/09/28/2751198/0/en/Coave-Therapeutics-to-Present-at-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2023/09/21/2747076/0/en/Coave-Therapeutics-Appoints-Genetic-Medicine-Expert-Lolita-Petit-PhD-as-Chief-Scientific-Officer.html
https://www.globenewswire.com/news-release/2023/05/31/2679143/0/en/Coave-Therapeutics-announces-Positive-12-months-Data-from-Ongoing-Phase-I-II-Clinical-Trial-of-CTx-PDE6b-in-Patients-with-Retinitis-Pigmentosa-Caused-by-Bi-allelic-Mutations-in-PDE.html
https://www.globenewswire.com/news-release/2023/05/17/2670676/0/en/Coave-Therapeutics-to-Participate-in-Upcoming-Conferences.html
https://www.globenewswire.com/news-release/2023/05/04/2661420/0/en/Coave-Therapeutics-Demonstrates-its-Modified-coAAV-Vectors-Outperform-AAV9-to-Address-Neurological-Disorders.html
https://www.globenewswire.com/news-release/2023/03/16/2628352/0/en/Coave-Therapeutics-to-Present-at-Upcoming-Conferences.html
https://www.prnewswire.com/news-releases/coave-therapeutics-strengthens-board-of-directors-301654757.html
Market Place
Share 
